author-photo

Levenia Baker

Pfizer

5

Papers

161

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

The Hepatoselective Glucokinase Activator PF-04991532 Ameliorates Hyperglycemia without Causing Hepatic Steatosis in Diabetic Rats

2014 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (30)
Optimizing glucokinase activator binding kinetics to lower in vivo hypoglycemia risk

2014 MedChemComm
Show All
- Source
- Cite
- Save
Citations (7)
Corrigendum to “The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of Type 2 diabetes mellitus” [Bioorg. Med. Chem. Lett. 22 (2012) 7100–7105]

2013 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (1)
Discovery of (S)-6-(3-Cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic Acid as a Hepatoselective Glucokinase Activator Clinical Candidate for Treating Type 2 Diabetes Mellitus

2012 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (94)
The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of type 2 diabetes mellitus.

2012 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (29)